The size and burden of mental disorders and other disorders of the brain in Europe 2010.
By Hans-Ulrich Wittchen, F. Jacobi, Jürgen Rehm, A. Gustavsson, Mikael Svensson, B. Jönsson, J. Olesen, C. Allgulander, J. Alonso, C. Faravelli and 9 more. European Neuropsychopharmacology, 2011
3,624 citations recorded by the source corpus.
Subfields: Education, Health, Toxicology and Mutagenesis, Social Psychology
View Paper: https://www.semanticscholar.org/paper/ebacf8aac183589063bc2bee177f4df793a3af01
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Education
In Social Psychology
- M. Reinhold
- Irene López-Gómez
- Carmelo Vázquez
- Gonzalo Hervás
- Tim Dalgleish
- David J. Nutt
- Heinz Holling
- Paul-Christian Burkner
Citations in the corpus
- Effects of expressive writing on depressive symptoms—A meta‐analysis (2018, background): “In comparison with other mental and physical disorders, depression leads to the highest decrease in the quality of life (Wittchen et al., 2011), and although depressive symptoms are common with a 12-month prevalence for major depression of 6.9% (Wittchen et al., 2011), only 14% of people with a…”
- A systematic review of reviews on the prevalence of anxiety disorders in adult populations (2016, background): “In the European Union (EU), 69 million people are affected by anxiety disorders in a given year, making them the most prevalent psychiatric conditions in the EU.(3) In 2010, they contributed to 26.”
- A Comparative Study on the Efficacy of a Positive Psychology Intervention and a Cognitive Behavioral Therapy for Clinical Depression (2017, background): “Depressive disorders affect up to 20 % of people at some time in their lives (Wittchen et al. 2011) and depression is expected to be the disorder with the highest disease burden in high-income countries by the year 2030 (Mathers and Loncar 2006).”
- Prevalence of antenatal and postnatal anxiety: Systematic review and meta-analysis (2017, result): “70,71 This is consistent with our results where we found no difference in prevalence rates for anxiety symptoms or disorders between studies published before 2010 and those published afterwards.”
- Amphetamine, past and present – a pharmacological and clinical perspective (2013, background): “Luckily, for reasons that are obscure, the recreational abuse methamphetamine has never really caught on in Europe, and almost all illegal use of the amphetamines is confined to d-amphetamine as the sulphate salt.”
- Hybrid carbon based nanomaterials for electrochemical detection of biomolecules (2017, background): “7 million people in the European Union member countries [1].”